OVATION Pharmaceuticals, Inc., a leading biopharmaceutical company based in Deerfield, Illinois, has been honored as a recipient of the 2007 Chicago Innovation Awards™.
OVATION is a fast growing biopharmaceutical company that develops and commercializes medically necessary therapies to satisfy unmet medical needs for patients with severe illnesses. Headquartered in Deerfield, Ill., with products available in more than 85 countries, OVATION is committed to having a significant impact on patients’ lives through its focus on central nervous system (CNS), hematology/oncology, and hospital-based therapies. The five launches the company expects over the next five years will be fueled by its late-stage CNS pipeline, which is one of the most robust in the industry. OVATION has been recognized for excellence in the global pharmaceutical and biotechnology industries with the 2006 “Pharma Company of the Year” award from Scrip magazine for small to mid-sized enterprises.
OVATION was recognized for its unique business model focused on developing medications for targeted populations of severely ill patients with unmet medical needs.
Now in its sixth year, the Chicago Innovation Awards recognize significant innovations introduced by Chicago-area organizations between May 1, 2006 and July 31, 2007. The award program is sponsored by the Chicago Sun-Times and Kuczmarski & Associates, a Chicago management consulting firm. OVATION is enriching lives by serving small and often silent populations of patients who otherwise would have nowhere to turn for the medications they need.
Kuczmarski & Associates and the Chicago Sun-Times established the Chicago Innovation Awards in 2002 as an annual program to honor significant innovations introduced by Chicago-area companies. Each year the Chicago Innovation Awards honor 10 winners who have introduced products or services that uniquely fill unmet needs, generate a competitive response in the marketplace, exceed market expectations and achieve financial success. For more information,